Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
- Authors
- Ageno, Walter; Becattini, Cecilia; Brighton, Timothy; Selby, Rita; Kamphuisen, Pieter W
- Year
- 2008
- Journal
- Circulation
- PMID
- 18086925
- DOI
- 10.1161/CIRCULATIONAHA.107.709204
BACKGROUND: The concept that venous thromboembolism (VTE) and atherosclerosis are 2 completely distinct entities has recently been challenged because patients with VTE have more asymptomatic atherosclerosis and more cardiovascular events than control subjects. We performed a meta-analysis to assess the association between cardiovascular risk factors and VTE. METHODS AND RESULTS: Medline and EMBASE databases were searched to identify studies that evaluated the prevalence of major cardiovascular risk factors in VTE patients and control subjects. Studies were selected using a priori defined criteria, and each study was reviewed by 2 authors who abstracted data on study characteristics, study quality, and outcomes. Odds ratios or weighted means and 95% confidence intervals (CIs) were then calculated and pooled using a random-effects model. Statistical heterogeneity was evaluated through the use of chi2 and I2 statistics. Twenty-one case-control and cohort studies with a total of 63 552 patients met the inclusion criteria. Compared with control subjects, the risk of VTE was 2.33 for obesity (95% CI, 1.68 to 3.24), 1.51 for hypertension (95% CI, 1.23 to 1.85), 1.42 for diabetes mellitus (95% CI, 1.12 to 1.77), 1.18 for smoking (95% CI, 0.95 to 1.46), and 1.16 for hypercholesterolemia (95% CI, 0.67 to 2.02). Weighted mean high-density lipoprotein cholesterol levels were significantly lower in VTE patients, whereas no difference was observed for total and low-density lipoprotein cholesterol levels. Significant heterogeneity among studies was present in all subgroups except for the diabetes mellitus subgroup. Higher-quality studies were more homogeneous, and significant associations remained unchanged. CONCLUSIONS: Cardiovascular risk factors are associated with VTE. This association is clinically relevant with respect to individual screening, risk factor modification, and primary and secondary prevention of VTE. Prospective studies should further investigate the underlying mechanisms of this relationship.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Obesity, smoking, and frontal brain dysfunction. | 2010 | 20716301 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Acute drug toxicity as a risk factor for lethal deep venous thrombosis. | Byard RW et al. | β | 2026 | β |
| A Growing mortality divide: demographic and regional disparities in thromboembolism with hypertension, U.S. 1999-2023. | Faheem MSB et al. | β | 2026 | β |
| Antithrombotic therapy in lower extremity peripheral artery disease patients with venous thromboembolism: a nationwide cohort study. | Goedegebuur J et al. | β | 2026 | β |
| Association Between High-Density Lipoprotein Characteristics and Hemostatic Parameters in the Netherlands Epidemiology of Obesity (NEO) Study-Brief Report. | Yuan L et al. | β | 2026 | β |
| Characteristics and outcomes of acute pulmonary embolism among patients with polyvascular, single-vascular or no atherosclerotic disease: insights from RIETE. | Cardi S et al. | β | 2026 | β |
| High-density lipoprotein subfractions and risk of future venous thromboembolism-the HUNT study. | RΓΈstvold IA et al. | β | 2026 | β |
| Perfluorooctane sulfonate (PFOS) causes dysfunction of erythrocytes by calcium dysregulation, and a diabetic condition exacerbates PFOS-induced prothrombotic activation. | Park H et al. | β | 2026 | β |
| Risk of Venous Thromboembolism with Pemafibrate in Dyslipidemia: A Nationwide, Retrospective, Cohort Study Using a Japanese Claims Database. | Ikeda K et al. | β | 2026 | β |
| Sex differences in venous thromboembolism outcomes: findings from the GARFIELD-VTE registry. | Prandoni P et al. | β | 2026 | β |
| Venous thromboembolism and 20-year cancer risk: a Danish population-based cohort study. | Martiny SK et al. | β | 2026 | β |
| Alterations in visible light exposure modulate platelet function and regulate thrombus formation. | Andraska EA et al. | β | 2025 | β |
| A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries. | Wei M et al. | β | 2025 | β |
| Arterial Cardiovascular Disease Risk After Venous Thromboembolism in Young Adults: A Danish Nationwide Cohort Study. | Scheres LJJ et al. | β | 2025 | β |
| Association Between Antidepressant Use and Risk of Venous Thromboembolism: A Systematic Review and Meta-Analysis. | Uh M et al. | β | 2025 | β |
| Association between serum triglyceride levels and venous thrombosis risk in older Chinese patients with fractures: a retrospective cross-sectional study. | Gong YQ et al. | β | 2025 | β |
| Association between type 1 diabetes mellitus and esophageal varices: a Mendelian randomization study. | Feng K et al. | β | 2025 | β |
| Association of iron deficiency and anemia with obesity among children: A systematic review and meta-analysis. | Sachdeva M et al. | β | 2025 | β |
| Association of post-thrombotic syndrome with metabolic syndrome and inflammation - a systematic review. | Alturky S et al. | β | 2025 | β |
| Burden of Atherosclerosis and Outcomes of Acute Pulmonary Embolism: A Post Hoc Analysis of the Hokusai-VTE Trial. | Christodoulou KC et al. | β | 2025 | β |
| Characteristics and outcomes of thromboembolism following cardiac transplant: a multi-institutional retrospective study. | Rizaldi AA et al. | β | 2025 | β |
| Comparative Efficacy and Safety of Direct Oral Anticoagulants and Warfarin in Morbidly Obese Patients (BMI \>40 kg/m2): A Systematic Review and Meta-Analysis. | Sagris M et al. | β | 2025 | β |
| Coronary heart disease with pulmonary embolism: A case report. | Xu JQ et al. | β | 2025 | β |
| Developing a predictive model for lower extremity deep vein thrombosis in acute ischemic stroke using a nomogram. | Chen W et al. | β | 2025 | β |
| Evaluation of pharmacological thromboprophylaxis in critically Ill elderly patients: A multicenter cohort Study. | Alqahtani R et al. | β | 2025 | β |
| Evolving Role of Double and Triple Therapy With GLP-1 Receptor Agonists in Obesity and Cardiovascular Disease. | Sedrak P et al. | β | 2025 | β |
| Extended Treatment of Provoked Venous Thromboembolism. | Jacob SCB et al. | β | 2025 | β |
| Extended Treatment of Provoked Venous Thromboembolism. | Demirci Εahin A et al. | β | 2025 | β |
| Extended Treatment of Provoked Venous Thromboembolism. | Tazi Mezalek Z | β | 2025 | β |
| Extended Treatment of Provoked Venous Thromboembolism. | Calvello J | β | 2025 | β |
| Extended Treatment of Provoked Venous Thromboembolism. Reply. | Piazza G et al. | β | 2025 | β |
| Hemostasis Testing in the Emergency Department: A Narrative Review. | Thonon H et al. | β | 2025 | β |
| Hemostatic alterations in metabolic dysfunction-associated steatotic liver disease (MASLD) and their link to venous thromboembolism (VTE). | GonzΓ‘lez-Mendoza DE et al. | β | 2025 | β |
| Hepatic Apolipoprotein M Suppresses Hepatocyte Secretion of Prothrombin by Upregulating Arid5B. | Kurano M et al. | β | 2025 | β |
| Impact of cardiovascular-kidney-metabolic syndrome staging on clinical outcomes and management of acute pulmonary embolism: A comprehensive analysis. | Cherevatsky SZ et al. | β | 2025 | β |
| Iron deficiency and iron deficiency anemia and their association with pulmonary embolism. | BΓ‘ez-Ferrer N et al. | β | 2025 | β |
| Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database. | Εaszkiewicz J et al. | β | 2025 | β |
| Obesity and cardiovascular disease: an ESC clinical consensus statement. | Koskinas KC et al. | β | 2025 | β |
| Positive association between stress hyperglycemia ratio and ICU mortality in patients with pulmonary embolism: A retrospective study. | Liao J et al. | β | 2025 | β |
| Prothrombotic State and Vascular Damage in Angiotensin II-Induced Hypertension: Influence of Waterpipe Smoke Exposure. | Beegam S et al. | β | 2025 | β |
| Regulation of Platelet Function by HDL. | Pilard M et al. | β | 2025 | β |
| Risk factors for venous thromboembolism after hip arthroscopy: a systematic review and meta-analysis. | Li H et al. | β | 2025 | β |
| Risk of venous thromboembolism in the transgender population on hormone therapy: A systematic review. | Franco-Moreno A et al. | β | 2025 | β |
| Role of PCSK9 inhibitors in venous thromboembolism: current evidence and unmet clinical needs. | Zuin M et al. | β | 2025 | β |
| Smart Technology Facilitated Patient-Centered Venous Thromboembolism Management (the SmaVTE Study): Protocol for a Randomized Controlled Trial. | Jin ZG et al. | β | 2025 | β |
| Symptomatic venous thromboembolism after transsphenoidal surgery in Cushing's disease: incidence and risk factors. | Mikamoto M et al. | β | 2025 | β |
| Temporal trends in hospitalisations for venous thromboembolic events in England: a population-level analysis. | Hughes M et al. | β | 2025 | β |
| Testosterone-induced erythrocytosis: addressing the challenge of metabolic syndrome and widely prescribed SGLT2-inhibitor drugs. | Tramontana F et al. | β | 2025 | β |
| The APROVE (Anti-coagulation/Platelet Treatment in Pancreatic Resections Involving Vascular Reconstruction) Study: Results from a Worldwide Survey. | Marchetti A et al. | β | 2025 | β |
| The Link between Arterial Atherosclerotic Disease and Venous Thromboembolic Disease. | Poredos P et al. | β | 2025 | β |
| The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction? | Donadini MP et al. | β | 2025 | β |
| The Recurrence of Venous Thromboembolism in Obstructive Sleep Apnea: A Narrative Review. | Gholinataj Jelodar M et al. | β | 2025 | β |
| Venous thromboembolism with contraceptive use in females with sickle cell trait. | Phillips AK et al. | β | 2025 | β |
| Venous thrombosis and obesity: from clinical needs to therapeutic challenges. | La Rosa F et al. | β | 2025 | β |
| Vitamin D Supplementation Effects on Markers Related with Endothelial Function and Coagulation in Obese Orthopedic Patients: Insights from Acute and Chronic Cases. | GawryjoΕek M et al. | β | 2025 | β |
| A Case Report of Urinary Tract Infection and Fungemia Due to <i>Pichia ohmeri</i> Complicated with Pulmonary Thromboembolism. | Sun JJ et al. | β | 2024 | β |
| Acute Pulmonary Embolism: Evidence, Innovation, and Horizons. | Henkin S et al. | β | 2024 | β |
| Analysis of Deep Vein Thrombosis: A Prospective Observational Study. | Ali IM et al. | β | 2024 | β |
| Analysis of thromboembolism and prognosis in metastatic pancreatic cancer from the Tokushukai REAlβworld data project. | Shimoyama R et al. | β | 2024 | β |
| Association between Mid-Term Functionality and Clinical Severity in Patients Hospitalized for Pulmonary Embolism. | GΓ‘miz-Molina AB et al. | β | 2024 | β |
| Association between venous thromboembolism and atrial fibrillation: a Mendelian randomization study. | Dang C et al. | β | 2024 | β |
| Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum. | Li Q et al. | β | 2024 | β |
| Causal effect of atrial fibrillation on pulmonary embolism: a mendelian randomization study. | Liu G et al. | β | 2024 | β |
| Clinical profile and long-term predictors of mortality in idiopathic acute pulmonary thromboembolism. | Parikh R et al. | β | 2024 | β |
| Comparison of enoxaparin 40Β mg versus 60Β mg dosage for venous thromboprophylaxis in patients undergoing bariatric surgery: A randomized controlled trial. | Kongsawat K et al. | β | 2024 | β |
| Coronary heart disease with pulmonary embolism: a case report | Xu J et al. | β | 2024 | β |
| Deep Vein Thrombosis as the Presenting Sign in an Adolescent With New-Onset Type 2 Diabetes. | Cooper F et al. | β | 2024 | β |
| Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights. | Jia G et al. | β | 2024 | β |
| Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications. | Talerico R et al. | β | 2024 | β |
| Effects of Obesity on Systemic Complications After Operative Pelvic Ring Fractures. | Patel M et al. | β | 2024 | β |
| Exploring Risk Factors for Lower Extremity Deep Vein Thrombosis Patients with Co-existing Pulmonary Embolism Based on Multiple Logistic Regression Model. | Zu J et al. | β | 2024 | β |
| Factors Associated with Hospital Length of Stay among VTE Cases: Insights from the i-RegVed Registry. | Aggarwal S et al. | β | 2024 | β |
| Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: the Medical Inpatients Thrombosis and Hemostasis study. | Repp AB et al. | β | 2024 | β |
| Gene expression profiling in Venous thromboembolism: Insights from publicly available datasets. | Arya S et al. | β | 2024 | β |
| How I treat the co-occurrence of venous and arterial thromboembolism: anticoagulation, antiplatelet therapy, or both? | May JE et al. | β | 2024 | β |
| Hyperglycemia and Venous Thromboembolism. | Panchagnula N et al. | β | 2024 | β |
| Increased Risk of Postoperative Complications in Patients Who Have Obstructive Sleep Apnea Undergoing Total Joint Arthroplasty: A Systematic Review and Meta-Analysis. | Thomas TL et al. | β | 2024 | β |
| Independent Risk Factors Associated With Venous Thromboembolism After Knee Arthroscopy: A Retrospective Study of 222 Patients. | Wu J et al. | β | 2024 | β |
| Is fluid retention a cardiovascular risk factor? | Blankfield RP | β | 2024 | β |
| Machine learning-based model for prediction of deep vein thrombosis after gynecological laparoscopy: A retrospective cohort study. | Chen X et al. | β | 2024 | β |
| Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis. | Amjad W et al. | β | 2024 | β |
| Metabolomic profiling of deep vein thrombosis. | Jiang W et al. | β | 2024 | β |
| Multiple risk factors are associated with an incremental increase in acute venous thromboembolism risk after total joint arthroplasty: A pearldiver cohort study. | Kumar M et al. | β | 2024 | β |
| No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study. | Du HC et al. | β | 2024 | β |
| Obesity and cardiovascular disease: an ESC clinical consensus statement. | Koskinas KC et al. | β | 2024 | β |
| Oxidative Status, Iron Plasma Levels in Venous Thrombosis Patients. | Signorelli SS et al. | β | 2024 | β |
| Predictors for the Development of Thromboembolic Events in Cancer Patients Treated with Bevacizumab, Ramucirumab, and Aflibercept: A Single-Institution Retrospective Analysis. | Kanbayashi Y et al. | β | 2024 | β |
| Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies. | Stupia R et al. | β | 2024 | β |
| Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity. | Sperry JD et al. | β | 2024 | β |
| Reviewing the Rare Association Between Progestogen-only Implant and Pulmonary Embolism in a Woman with Multiple Cardiovascular Risk Factors: A Case Report. | Owolabi A et al. | β | 2024 | β |
| Risk factors of thromboembolic events in patients with scrub typhus. | Ki YJ et al. | β | 2024 | β |
| Risk of Bleeding and Venous Thromboembolism after Colorectal Cancer Surgery in Patients with and without Type 2 Diabetes: A Danish Cohort Study. | Kristensen FPB et al. | β | 2024 | β |
| Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis Patients. | Charles-Schoeman C et al. | β | 2024 | β |
| Sex-specific differences in the clinical profile among psychiatric patients with pulmonary Embolism: a hospital-based retrospective study. | Kong L et al. | β | 2024 | β |
| Sodium-glucose co-transporter-2 inhibitors and the risk of venous thromboembolism: A nationwide population-based study and meta-analysis. | Tsai HR et al. | β | 2024 | β |
| Statins and Venous Thromboembolic Disease - Where are we Now? | PoredoΕ‘ P et al. | β | 2024 | β |
| Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2. | Mabuchi H et al. | β | 2024 | β |
| The Effect of Diabetes on Complications after Spinal Fusion: A Systematic Review and Meta-Analysis. | Ruggiero N et al. | β | 2024 | β |
| Unexplained Multi-Site Thrombosis: A Step-by-Step Strategy for Factor V Leiden Detection in a Hypercoagulable Patient. | Shahabi Raberi V et al. | β | 2024 | β |
| Venous Thromboembolism in Patients Hospitalized for COVID-19 in a Non-Intensive Care Unit. | Mackiewicz-Milewska M et al. | β | 2024 | β |
| A bidirectional Mendelian randomized study of classical blood lipids and venous thrombosis. | Lin L et al. | β | 2023 | β |
| Acute myocardial infarction after initially diagnosed with unprovoked venous thromboembolism: A case report. | Seo J et al. | β | 2023 | β |
| Acute Pulmonary Embolism in Oman: A Situational Analysis. | Al Harrasi S et al. | β | 2023 | β |
| Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia. | Alvarez-LarrΓ‘n A et al. | β | 2023 | β |
| Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy. | Ha H et al. | β | 2023 | β |
| Arteriovenous thrombosis, a complication of induction therapy with all-trans retinoic acid for acute promyelocytic leukemia: A case report. | Tondro Anamag F et al. | β | 2023 | β |
| Assessing causality between different risk factors and pulmonary embolism: A Mendelian randomization study. | Wei JM et al. | β | 2023 | β |
| Association between cardiovascular risk factors and atrial fibrillation. | Wu G et al. | β | 2023 | β |
| Association between diabetes and venous thromboembolism: A systematic review and meta-analysis. | Ding C et al. | β | 2023 | β |
| Association between hyperthyroidism and thromboembolism: A retrospective observational study. | Alsaidan AA et al. | β | 2023 | β |
| Association of Left Ventricular Filling Pressure With Chronic Thromboembolic Pulmonary Hypertension: A Matter of Perspective. | Forfia PR | β | 2023 | β |
| Association of total cholesterol variability with risk of venous thromboembolism: A nationwide cohort study. | Park H et al. | β | 2023 | β |
| Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies. | Nazarzadeh M et al. | β | 2023 | β |
| Body Mass Index and Waist Circumference as Determinants of Hemostatic Factors in Participants of a Population-Based Study. | Iglesias Morcillo M et al. | β | 2023 | β |
| Cardiovascular risk factors and venous thromboembolism in Kingdom of Saudi Arabia: A meta-analysis and systemic review. | Alsulami SS et al. | β | 2023 | β |
| Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Obesity. | Hattaway Q et al. | β | 2023 | β |
| Egg and cholesterol intake, apoE4 phenotype and risk of venous thromboembolism: findings from a prospective cohort study. | Kunutsor SK et al. | β | 2023 | β |
| Evaluation of a gene signature related to thrombotic manifestations in antiphospholipid syndrome. | Jacintho BC et al. | β | 2023 | β |
| Exploring phenotypes of deep vein thrombosis in relation to clinical outcomes beyond recurrence. | Iding AFJ et al. | β | 2023 | β |
| Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism. | Ghouse J et al. | β | 2023 | β |
| High-Efficiency Fermentation of Nattokinase by Recombinant <i>PSP2</i> Using Oyster Protein Hydrolysate as a Substrate. | Tian M et al. | β | 2023 | β |
| <i>MTHFR</i> gene polymorphisms and susceptibility to myocardial infarction: Evidence from meta-analysis and trial sequential analysis. | Samii A et al. | β | 2023 | β |
| Integrin Ξ² Expression as a New Diagnostic Marker for Arteriovenous Thrombosis: A Single-Center Prospective Study. | Xi Y et al. | β | 2023 | β |
| Just What the Doctor Ordered: Missed Ordering of Venous Thromboembolism Chemoprophylaxis Is Associated With Increased VTE Events in High-risk General Surgery Patients. | Baimas-George MR et al. | β | 2023 | β |
| Life's Essential 8 is associated with atherosclerotic cardiovascular disease but not venous thromboembolism in men: a prospective cohort study. | Isiozor NM et al. | β | 2023 | β |
| Mendelian Randomization Study Does Not Support a Bidirectional Link between Atherosclerosis and Venous Thromboembolism. | Hu M et al. | β | 2023 | β |
| Plasma protein and venous thromboembolism: prospective cohort and mendelian randomisation analyses. | Yuan S et al. | β | 2023 | β |
| Preoperative D-dimer Value and Lower Limb Venous Ultrasound for Deep Venous Thrombosis Prevents Postoperative Symptomatic Venous Thromboembolism in Patients Undergoing Colorectal Surgery: A Retrospective Study. | Imamura H et al. | β | 2023 | β |
| Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study. | Yap ES et al. | β | 2023 | β |
| Pulmonary thromboembolism and obesity in forensic pathologic case work. | Klintschar M et al. | β | 2023 | β |
| Racial disparities in reasons for mortality following bariatric surgery. | Edwards MA et al. | β | 2023 | β |
| Redefining clinical venous thromboembolism phenotypes: aΒ novel approach using latent class analysis. | de Winter MA et al. | β | 2023 | β |
| Risk factors for venous thromboembolism in patients with pneumonia in the pre-COVID-19 era: a meta-analysis and systematic review. | Xu F et al. | β | 2023 | β |
| Risk of Incident Venous Thromboembolism Among Patients With Bullous Pemphigoid or Pemphigus Vulgaris: A Nationwide Cohort Study With Meta-Analysis. | Chen TL et al. | β | 2023 | β |
| Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis | Birdal O et al. | β | 2023 | β |
| Strategies involving low-molecular-weight heparin for the treatment and prevention of venous thromboembolism in patients with obesity: A systematic review and meta-analysis. | Liu J et al. | β | 2023 | β |
| Study on the Mechanism of NLRP3/IL-1/ NF-ΞΊB Signaling Pathway and Macrophage Polarization in the Occurrence and Development of VTE. | Abuduhalike R et al. | β | 2023 | β |
| The Caprini Risk Score for Early Prediction of Mortality in Patients With Acute Coronary Syndrome. | Li W et al. | β | 2023 | β |
| The Causality between Diabetes and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study. | Hu S et al. | β | 2023 | β |
| Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients. | Pastori D et al. | β | 2023 | β |
| Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data. | Jamieson MJ et al. | β | 2022 | β |
| Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength. | Jones WL et al. | β | 2022 | β |
| Association Between Blood Lipid Levels and Lower Extremity Deep Venous Thrombosis: A Population-Based Cohort Study. | Huang Y et al. | β | 2022 | β |
| Association between cardiovascular risk factors and venous thromboembolism in the elderly. | Wang H et al. | β | 2022 | β |
| Association between pre-admission anticoagulation and in-hospital death, venous thromboembolism, and major bleeding among hospitalized COVID-19 patients in Japan. | Adomi M et al. | β | 2022 | β |
| Association Between Simultaneous Bilateral Total Hip Arthroplasty Without Any Anticoagulant or Antiplatelet Therapy and Deep Venous Thrombosis: A Cohort Study. | Hatano M et al. | β | 2022 | β |
| Association of Metformin Use With Risk of Venous Thromboembolism in Adults With Type 2 Diabetes: A General-Population-Based Cohort Study. | Sha T et al. | β | 2022 | β |
| Association of venous thromboembolism between hydrophilic and lipophilic statin users among diabetic subjects. | Hu WS et al. | β | 2022 | β |
| Atherosclerosis and Its Impact on the Outcomes of Patients with Deep Venous Thrombosis. | Keller K et al. | β | 2022 | β |
| Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH. | Mutch NJ et al. | β | 2022 | β |
| Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism. | Schmitt VH et al. | β | 2022 | β |
| Differences in the risk of cardiovascular disease across ethnic groups: UK Biobank observational study. | Razieh C et al. | β | 2022 | β |
| Efficacy of a hypolipid diet in patients with primary antiphospholipid syndrome with dyslipidemia: a prospective study. | Rodrigues TCR et al. | β | 2022 | β |
| Epidemiological Study Regarding the Incidence of Venous Thromboembolism in Patients After Cancer Remission. | Imura M et al. | β | 2022 | β |
| Extracellular Vesicles Derived from 3T3-L1 Adipocytes Enhance Procoagulant Activity. | Nakatani E et al. | β | 2022 | β |
| Incidence and risk factors of venous thromboembolism in men and women. | Lind MM et al. | β | 2022 | β |
| Metabolic Disorders and Risk of Portal Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis. | Li J et al. | β | 2022 | β |
| No evidence of a prospective relationship between serum zinc and venous thromboembolism in Caucasian men: a cohort study. | Kunutsor SK et al. | β | 2022 | β |
| Obesity as a Risk Factor for Venous Thromboembolism Recurrence: A Systematic Review. | Ntinopoulou P et al. | β | 2022 | β |
| Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society. | Klok FA et al. | β | 2022 | β |
| Oral Janus kinase inhibitors and venous thromboembolic events in atopic dermatitis: protocols for a case-time control study and a nested case-control study based on the French national health insurance (SNDS) cohort. | Berthe P et al. | β | 2022 | β |
| Predictors of Deep Venous Thrombosis in Hospitalized Patients With Liver Cirrhosis in the US. | Abou Yassine A et al. | β | 2022 | β |
| Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone. | Berkowitz SD et al. | β | 2022 | β |
| Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data. | Giorgi-Pierfranceschi M et al. | β | 2022 | β |
| Pulmonary Embolism After in vitro Fertilization and Cesarean Section: Two Case Reports and Brief Review of the Literature. | Wu YY et al. | β | 2022 | β |
| Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease. | Fujiya M et al. | β | 2022 | β |
| Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data. | Dawwas GK et al. | β | 2022 | β |
| Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization. | Hess CN et al. | β | 2022 | β |
| Role of von Willebrand factor in venous thromboembolic disease. | Michels A et al. | β | 2022 | β |
| Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review. | Rajashekar S et al. | β | 2022 | β |
| The Interplay of Race/Ethnicity and Obesity on the Incidence of Venous Thromboembolism. | Weze KO et al. | β | 2022 | β |
| The mean platelet volume and atherosclerotic cardiovascular-risk factors in adults with obesity: a systematic review and meta-analysis of observational studies. | Nkambule BB et al. | β | 2022 | β |
| The Need for Individualized Risk Assessment in Cardiovascular Disease. | Lim HY et al. | β | 2022 | β |
| The venous system during pregnancy. Part 1: physiologic considerations. | Tsen LC et al. | β | 2022 | β |
| Upper extremity deep vein thrombosis in COVID-19: Incidence and correlated risk factors in a cohort of non-ICU patients. | Mumoli N et al. | β | 2022 | β |
| A comparison of perioperative safety for breast augmentation in cis- <i>vs</i>. trans patients. | Gabrick KS et al. | β | 2021 | β |
| Acute lower extremity arterial thrombosis after intraocular foreign body removal under general anesthesia: A case report and review of literature. | Jeon S et al. | β | 2021 | β |
| Assessment of empiric body mass index-based thromboprophylactic dosing of enoxaparin after bariatric surgery: evidence for dosage adjustment using anti-factor Xa in high-risk patients. | Karas LA et al. | β | 2021 | β |
| Association between body mass index, waist circumference, and relative fat mass with the risk of first unprovoked venous thromboembolism. | Caiano LM et al. | β | 2021 | β |
| Association between cardiovascular risk factors and colorectal cancer: A systematic review and meta-analysis of prospective cohort studies. | Zhang C et al. | β | 2021 | β |
| Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women. | MacDonald CJ et al. | β | 2021 | β |
| Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE. | Elbagir S et al. | β | 2021 | β |
| Case of right ventricular and aortic thrombi in a patient with severe COVID-19. | Afari H et al. | β | 2021 | β |
| Circulating Serum Copper Is Associated with Atherosclerotic Cardiovascular Disease, but Not Venous Thromboembolism: A Prospective Cohort Study. | Kunutsor SK et al. | β | 2021 | β |
| Circulating Serum Magnesium and the Risk of Venous Thromboembolism in Men: A Long-Term Prospective Cohort Study. | Kunutsor SK et al. | β | 2021 | β |
| Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis. | Elshafei MN et al. | β | 2021 | β |
| Correlation between serum factor VIII:C levels and deep vein thrombosis following gynecological surgery. | Liu J et al. | β | 2021 | β |
| Current practice and effects of intravenous anticoagulant therapy in hospitalized acute heart failure patients with sinus rhythm. | Nakano H et al. | β | 2021 | β |
| Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE). | Zhang X et al. | β | 2021 | β |
| Derivation and validation of a clinical prediction model for risks of venous thromboembolism in diabetic and general populations. | Lin CC et al. | β | 2021 | β |
| Derivation and validation of a nomogram model for pulmonary thromboembolism in patients undergoing lung cancer surgery. | Li Y et al. | β | 2021 | β |
| Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients. | Lin YS et al. | β | 2021 | β |
| Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli. | Lachant DJ et al. | β | 2021 | β |
| Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism. | Hinton W et al. | β | 2021 | β |
| Effect of Ξ±2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism. | BarΓ‘th B et al. | β | 2021 | β |
| Evaluation of Deep Vein Thrombosis Risk Factors After Arthroscopic Posterior Cruciate Ligament Reconstruction: A Retrospective Observational Study. | Ying P et al. | β | 2021 | β |
| Extensive thrombosis after COVID-19 vaccine: cause or coincidence? | GraΓ§a LL et al. | β | 2021 | β |
| Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States. | Montano D | β | 2021 | β |
| Incidence and Risk Factors for Postoperative Venous Thromboembolic Events in Patients Undergoing Cervical Spine Surgery. | Bui A et al. | β | 2021 | β |
| Incidence and Risk Factors for Venous Thromboembolism Following 2462 Major Abdomino-Pelvic Surgeries in Tertiary Hospital. | Taengsakul N et al. | β | 2021 | β |
| Incidence of deep venous thrombosis in patients with both Pulmonary Embolism and COPD. | Castellana G et al. | β | 2021 | β |
| Isolated severe blunt traumatic brain injury: effect of obesity on outcomes. | Cone JT et al. | β | 2021 | β |
| Lifestyle factors and venous thromboembolism in two cohort studies. | Yuan S et al. | β | 2021 | β |
| Lifestyle Intervention Improves Prothrombotic Coagulation Profile in Individuals at High Risk for Type 2 Diabetes. | HΓΆrber S et al. | β | 2021 | β |
| Long-term outcomes in patients with pulmonary embolism: results from a longitudinal cohort study. | Lamba M et al. | β | 2021 | β |
| Neurological Complications of Pulmonary Embolism: a Literature Review. | Desai PV et al. | β | 2021 | β |
| Potential Association between Distal Deep Vein Thrombosis and Asymptomatic Atherosclerosis. | Adamo A et al. | β | 2021 | β |
| Predictable Risk Factors of Upper-Extremity Deep Venous Thrombosis in a Level I Trauma Center. | Tohme S et al. | β | 2021 | β |
| Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. | Xiong X et al. | β | 2021 | β |
| Prevalence of thromboembolic events and status of prophylactic anticoagulant therapy in hospitalized patients with COVID-19 in Japan. | Fujiwara S et al. | β | 2021 | β |
| Primary laparoscopic sleeve gastrectomy versus gastric bypass: a propensity-matched comparison of 30-day outcomes. | Kapur A et al. | β | 2021 | β |
| Racial disparities in COVID-19 associated pulmonary embolism: A multicenter cohort study. | Metra B et al. | β | 2021 | β |
| Relations of arterial stiffness and endothelial dysfunction with incident venous thromboembolism. | Ko D et al. | β | 2021 | β |
| Risk factors associated with deep venous thrombosis in patients with different bed-rest durations: A multi-institutional case-control study. | Cao J et al. | β | 2021 | β |
| Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis? | Ozen G et al. | β | 2021 | β |
| Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States. | Faiz AS et al. | β | 2021 | β |
| (S029) Managing therapeutic anticoagulation in bariatric surgery patients. | Shea B et al. | β | 2021 | β |
| Serum Metabolic Profiles Based on Nuclear Magnetic Resonance Spectroscopy among Patients with Deep Vein Thrombosis and Healthy Controls. | Escobar MQ et al. | β | 2021 | β |
| Subacute combined degeneration of the spinal cord concurrent with acute pulmonary embolism: a case report. | Pang X et al. | β | 2021 | β |
| The hematologic consequences of obesity. | Purdy JC et al. | β | 2021 | β |
| The Incidence, Risk Factors, and Patterns of Peripherally Inserted Central Catheter-Related Venous Thrombosis in Cancer Patients Followed Up by Ultrasound. | Li X et al. | β | 2021 | β |
| The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations. | Ashton V et al. | β | 2021 | β |
| The Prognostic Value of the Serum Levels of Brain Natriuretic Peptide, Troponin I, and D-Dimer, in Addition to the Neutrophil-to-Lymphocyte Ratio, for the Disease Evaluation of Patients with Acute Pulmonary Embolism. | Bi W et al. | β | 2021 | β |
| Use of the ZDF rat to model dietary fat induced hypercoagulability is limited by progressive and fatal nephropathy. | Pugsley MK et al. | β | 2021 | β |
| Validation of obesity-related diagnosis codes in claims data. | Suissa K et al. | β | 2021 | β |
| Weight-adjusted versus fixed dose heparin thromboprophylaxis in hospitalized obese patients: A systematic review and meta-analysis. | Ceccato D et al. | β | 2021 | β |
| 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). | Konstantinides SV et al. | β | 2020 | β |
| A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery. | van Oosterom N et al. | β | 2020 | β |
| An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis. | Markowicz-Piasecka M et al. | β | 2020 | β |
| Arterial and venous thrombosis: What's the link? A narrative review. | Delluc A et al. | β | 2020 | β |
| Associations of Serum Lipids and Deep Venous Thrombosis Risk After Total Knee Arthroplasty in Patients With Primary Knee Osteoarthritis. | Dai X et al. | β | 2020 | β |
| Brain Natriuretic Peptide and Troponin T in Patients With Acute Pulmonary Embolism and Grade 3 Obesity: A Retrospective Analysis. | Borz-Baba C et al. | β | 2020 | β |
| Cerebral Venous Thrombosis Associated with COVID-19. | Cavalcanti DD et al. | β | 2020 | β |
| Comorbidity and risk of venous thromboembolism after hospitalization for first-time myocardial infarction: A population-based cohort study. | WΓΌrtz M et al. | β | 2020 | β |
| Comparison of Outcomes between Obese and Non-Obese Patients in a Colorectal Enhanced Recovery After Surgery (ERAS) Program: A Single-Center Cohort Study. | Iranmanesh P et al. | β | 2020 | β |
| Direct Oral Anticoagulants in Obesity: An Updated Literature Review. | Sebaaly J et al. | β | 2020 | β |
| Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review. | Abildgaard A et al. | β | 2020 | β |
| Elevated HbA1c is not associated with recurrent venous thromboembolism in the elderly, but with all-cause mortality- the SWEETCO 65+ study. | Mathis A et al. | β | 2020 | β |
| Gamer's Thrombosis: A Review of Published Reports. | Rambaran KA et al. | β | 2020 | β |
| Handgrip strength is not associated with risk of venous thromboembolism: a prospective cohort study. | Kunutsor SK et al. | β | 2020 | β |
| Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors. | Hultcrantz M et al. | β | 2020 | β |
| How to optimise anticoagulation for patients who are obese. | Raja H et al. | β | 2020 | β |
| Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters. | Bertaggia Calderara D et al. | β | 2020 | β |
| Identification of common and divergent gene expression signatures in patients with venous and arterial thrombosis using data from public repositories. | Hounkpe BW et al. | β | 2020 | β |
| Impact of cardiovascular risk factors on the clinical presentation and survival of pulmonary embolism without identifiable risk factor. | RodrΓguez-NΓΊΓ±ez N et al. | β | 2020 | β |
| Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad TromboembΓ³lica Registry. | Golemi I et al. | β | 2020 | β |
| Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data. | Mease P et al. | β | 2020 | β |
| Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer. | Salinaro JR et al. | β | 2020 | β |
| Incidence of venous thromboembolism following initiation of non-steroidal anti-inflammatory drugs in U.S. women. | Kinsey TL et al. | β | 2020 | β |
| Influence of Tobacco Smoking on Perioperative Risk of Venous Thromboembolism. | Al-Nasser B | β | 2020 | β |
| Interaction between fasting blood glucose and tumor embolus in predicting the postoperative prognosis of 4330 Chinese patients with gastrointestinal tract cancer. | Hu D et al. | β | 2020 | β |
| Is there a link between venous and arterial thrombosis? A reappraisal. | Prandoni P | β | 2020 | β |
| <i>Vitis labrusca</i> Extract (HP01) Improves Blood Circulation and Lipid Metabolism in Hyperlipidemic Rats. | Chang BY et al. | β | 2020 | β |
| Missing something? A scoping review of venous thromboembolic events and their associations with bariatric surgery. Refining the evidence base. | El Ansari W et al. | β | 2020 | β |
| Morbid Obesity and Mortality in Patients With VTE: Findings From Real-Life Clinical Practice. | Giorgi-Pierfranceschi M et al. | β | 2020 | β |
| Obesity in adolescent men increases the risk of venous thromboembolism in adult life. | Glise Sandblad K et al. | β | 2020 | β |
| Obstetric haemorrhage and risk of cardiovascular disease after three decades: a population-based cohort study. | Ukah UV et al. | β | 2020 | β |
| Obstructive sleep apnea and venous thromboembolism: Overview of an emerging relationship. | Alonso-FernΓ‘ndez A et al. | β | 2020 | β |
| Physical activity and risk of venous thromboembolism: systematic review and meta-analysis of prospective cohort studies. | Kunutsor SK et al. | β | 2020 | β |
| Physical Activity as an Effect Modifier of the Association Between Obesity and Venous Thromboembolism: A Danish Population-Based Cohort Study. | Solli H et al. | β | 2020 | β |
| Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and MajorΒ Thromboembolic Events in MedicallyΒ IllΒ Patients. | Spyropoulos AC et al. | β | 2020 | β |
| Risk of Stroke in Patients With Patent Foramen Ovale Who Had Pulmonary Embolism. | Roy S et al. | β | 2020 | β |
| The gut microbiome and thromboembolism. | Hasan RA et al. | β | 2020 | β |
| Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study. | Peng YH et al. | β | 2020 | β |
| Venous thromboembolic events after bariatric surgery: Protocol for a systematic review and meta-analysis. | El Ansari W et al. | β | 2020 | β |
| Weight change over 9 years and subsequent risk of venous thromboembolism in the ARIC cohort. | French SA et al. | β | 2020 | β |
| 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). | Konstantinides SV et al. | β | 2019 | β |
| Abdominal visceral adipose tissue is associated with unsuspected pulmonary embolism on routine CT scans in patients with gastrointestinal cancer. | Xiao X et al. | β | 2019 | β |
| Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk. | Orsi FA et al. | β | 2019 | β |
| A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation. | Paquette M et al. | β | 2019 | β |
| Bariatric venous thromboembolism prophylaxis: an update on the literature. | Hamadi R et al. | β | 2019 | β |
| Cardiovascular Risk Factors Associated With Venous Thromboembolism. | Gregson J et al. | β | 2019 | β |
| Case series: Portomesenteric venous thrombosis complicating laparoscopic bariatric procedures. | Bucheeri MM et al. | β | 2019 | β |
| Changes in Childhood Body-Mass Index and Risk of Venous Thromboembolism in Adulthood. | SundbΓΈll J et al. | β | 2019 | β |
| Coronary artery calcification is associated with mortality independent of pulmonary embolism severity: a retrospective cohort study. | Williams MC et al. | β | 2019 | β |
| FSRH Guideline (April 2019) Overweight, Obesity and Contraception. | β | β | 2019 | β |
| Glucose metabolism affects coagulation factors: The NEO study. | van der Toorn FA et al. | β | 2019 | β |
| High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study. | Gao B et al. | β | 2019 | β |
| Impact of symptomatic atherosclerosis in patients with pulmonary embolism. | Keller K et al. | β | 2019 | β |
| Lipid Metabolism and Signaling in Platelet Function. | Paes AMA et al. | β | 2019 | β |
| Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII. | Olivieri O et al. | β | 2019 | β |
| Obesity is associated with postinjury hypercoagulability. | Samuels JM et al. | β | 2019 | β |
| Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications. | GarcΓa-Ortega A et al. | β | 2019 | β |
| Predicting venous thromboembolism following laparoscopic bariatric surgery: development of the BariClot tool using the MBSAQIP database. | Dang JT et al. | β | 2019 | β |
| Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients. | Nafee T et al. | β | 2019 | β |
| Reuniting overnutrition and undernutrition, macronutrients, and micronutrients. | Kim M et al. | β | 2019 | β |
| Risk factors and therapies in vascular diseases: An umbrella review of updated systematic reviews and meta-analyses. | Hong XY et al. | β | 2019 | β |
| Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study. | Tan L et al. | β | 2019 | β |
| Risk of Cardiovascular Disease Due to General Anesthesia and Neuraxial Anesthesia in Lower-Limb Fracture Patients: A Retrospective Population-Based Cohort Study. | Yeh HW et al. | β | 2019 | β |
| Risk of venous thromboembolism in patients with non-Hodgkin lymphoma surviving blood or marrow transplantation. | Gangaraju R et al. | β | 2019 | β |
| Sauna bathing reduces the risk of venous thromboembolism: a prospective cohort study. | Kunutsor SK et al. | β | 2019 | β |
| The Importance of a Standardized Screening Tool to Identify Thromboembolic Risk Factors in Pediatric Lower Extremity Arthroscopy Patients. | Ellis HB et al. | β | 2019 | β |
| Venous thromboemboli associated with acute aerobic exercise: A review of case report commonalities. | Taylor BA et al. | β | 2019 | β |
| Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor Study. | Gangaraju R et al. | β | 2019 | β |
| Venous thromboembolism prophylaxis using the Caprini score. | Golemi I et al. | β | 2019 | β |
| Adiposity throughout the life course and risk of venous thromboembolism. | Hagan KA et al. | β | 2018 | β |
| Anticoagulation at the extremes of body weight: choices and dosing. | McCaughan GJB et al. | β | 2018 | β |
| Body size measures and risk of venous thromboembolism: protocol for a systematic review and meta-analysis. | Kaze AD et al. | β | 2018 | β |
| Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism. | Carroll BJ et al. | β | 2018 | β |
| Current Practice Trends for Use of Early Venous Thromboembolism Prophylaxis After Intracerebral Hemorrhage. | Cherian LJ et al. | β | 2018 | β |
| Dosing of Enoxaparin in Morbidly Obese Patients: A Retrospective Cohort. | Czupryn MJ et al. | β | 2018 | β |
| Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations. | Sebaaly J et al. | β | 2018 | β |
| Epidemiology, Pathophysiology, and Natural History of Pulmonary Embolism. | Turetz M et al. | β | 2018 | β |
| European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the obese patient. | Venclauskas L et al. | β | 2018 | β |
| Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study. | Johansson M et al. | β | 2018 | β |
| Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients. | Ahmad A et al. | β | 2018 | β |
| Ideal Cardiovascular Health and Incident Cardiovascular Disease Among Adults: A Systematic Review and Meta-analysis. | RamΓrez-VΓ©lez R et al. | β | 2018 | β |
| Latest Innovations in the Treatment of Venous Disease. | Attaran RR | β | 2018 | β |
| Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease. | Eichinger S et al. | β | 2018 | β |
| Non-genetic and genetic risk factors for adult cerebral venous thrombosis. | Green M et al. | β | 2018 | β |
| Noninvasive label-free detection of circulating white and red blood clots in deep vessels with a focused photoacoustic probe. | Juratli MA et al. | β | 2018 | β |
| Obesity Paradox in Patients With Deep Venous Thrombosis. | El-Menyar A et al. | β | 2018 | β |
| Paired Analysis of Outcomes After Kidney Transplantation in Peritoneal and Hemodialysis Patients. | DΔbska-ΕlizieΕ A et al. | β | 2018 | β |
| Predictive Value of Oxidized Low-Density Lipoprotein/Ξ²<sub>2</sub>-Glycoprotein-I Complexes (oxLDL/Ξ²<sub>2</sub>GPI) in Nonautoimmune Atherothrombosis. | Ames PRJ et al. | β | 2018 | β |
| The diagnosis and treatment of venous thromboembolism in asian patients. | Wang KL et al. | β | 2018 | β |
| The Effect of a Simulated Commercial Flight Environment with Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants with Type 2 Diabetes - A Cross-over Study. | Konya J et al. | β | 2018 | β |
| The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study. | KrΓΆll D et al. | β | 2018 | β |
| Therapeutic approach for patients with venous thromboembolism attended in emergency departments during routine clinical practice: the EDITH study. | Ruiz-Artacho P et al. | β | 2018 | β |
| Venous thromboembolism laboratory testing (factor V Leiden and factor II c.*97G>A), 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG). | Zhang S et al. | β | 2018 | β |
| [Venous thromboembolism: What other risk factors in a North African population? A study of 276Β cases]. | Boukhris I et al. | β | 2018 | β |
| Venous thrombosis and breast cancer in older women: Racial differences in risk factors and mortality. | Faiz AS et al. | β | 2018 | β |
| An association between residual vein thrombosis and subclinical atherosclerosis: Cross-sectional study. | Prandoni P et al. | β | 2017 | β |
| Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. | Bengtsson K et al. | β | 2017 | β |
| Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies. | Mahmoodi BK et al. | β | 2017 | β |
| CE: Venous Thromboembolism: Updated Management Guidelines. | Roberts SH et al. | β | 2017 | β |
| Chronobiologic Aspects of Venous Thromboembolism. | Fantoni C et al. | β | 2017 | β |
| Clinical Presentation and Risk Factors of Venous Thromboembolic Disease. | Alhassan S et al. | β | 2017 | β |
| Deep venous thrombosis among diabetic patients in King Abdulaziz University (KAU) Hospital, Jeddah, Kingdom of Saudi Arabia. | Alotaibi HK et al. | β | 2017 | β |
| Deep Venous Thrombosis among hypertensive patients in King Abdulaziz University (KAU) Hospital, Jeddah, Kingdom of Saudi Arabia. | Alanazi OA et al. | β | 2017 | β |
| Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a "real-world" study. | Zhang Z et al. | β | 2017 | β |
| Dilemmas in the management of venous thromboembolism in older patients. | Shakeel M et al. | β | 2017 | β |
| Efficacy of standard dose unfractionated heparin for venous thromboembolism prophylaxis in morbidly obese and non-morbidly obese critically Ill patients. | Lee YR et al. | β | 2017 | β |
| Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients. | Hosch LM et al. | β | 2017 | β |
| High Altitude Is an Independent Risk Factor for Postoperative Symptomatic Venous Thromboembolism After Knee Arthroscopy: A Matched Case-Control Study of Medicare Patients. | Cancienne JM et al. | β | 2017 | β |
| Higher CHA<sub>2</sub>DS<sub>2</sub>-VASc Score Is Associated With Increased Mortality in Acute Pulmonary Embolism. | Onuk T et al. | β | 2017 | β |
| Impact of Obesity on Outcomes in Adults Undergoing Elective Posterior Cervical Fusion. | Phan K et al. | β | 2017 | β |
| Incidence of venous thromboembolism in care homes: a prospective cohort study. | Apenteng PN et al. | β | 2017 | β |
| Influences of Obesity and Bariatric Surgery on the Clinical and Pharmacologic Profile of Rivaroxaban. | Moore KT et al. | β | 2017 | β |
| Lipid levels and risk of venous thrombosis: results from the MEGA-study. | Morelli VM et al. | β | 2017 | β |
| Low Risk of Thromboembolic Events After Routine Administration of Tranexamic Acid in Hip and Knee Arthroplasty. | Madsen RV et al. | β | 2017 | β |
| Midlife risk factor exposure and incidence of cardiac arrest depending on cardiac or non-cardiac origin. | Ohlsson MA et al. | β | 2017 | β |
| Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk. | Deguchi H et al. | β | 2017 | β |
| Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability. | Brooks MB et al. | β | 2017 | β |
| Optimizing care for the obese patient in interventional radiology. | Aberle D et al. | β | 2017 | β |
| Pathogenesis and Epidemiology of Venous Thromboembolic Disease. | Patel K et al. | β | 2017 | β |
| Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery. | KrΓΆll D et al. | β | 2017 | β |
| Pulmonary embolism: Does the seasonal effect depend on age? A 12-year nationwide analysis of hospitalization and mortality. | OliΓ© V et al. | β | 2017 | β |
| Re: Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy: W. C. Duivenvoorden, S. Daneshmand, D. Canter, Y. Lotan, P. C. Black, H. Abdi, B. W. van Rhijn, E. E. Fransen van de Putte, P. Zareba, I. Koskinen, W. Kassouf, S. L. Traboulsi, J. E. Kukreja, P. J. BostrΓΆm, B. Shayegan and J. H. Pinthus J Urol 2016;196:1627-1633. | Ramos JD et al. | β | 2017 | β |
| Repair of Chronic Achilles Ruptures Has a High Incidence of Venous Thromboembolism. | Bullock MJ et al. | β | 2017 | β |
| Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the TromsΓΈ Study. | SmΓ₯brekke B et al. | β | 2017 | β |
| Risk of Pulmonary Embolism After Cerebral Venous Thrombosis. | Liberman AL et al. | β | 2017 | β |
| Smoking: A Dual Pathogen for Arterial and Venous Thrombosis. | Anand SS | β | 2017 | β |
| The effect of BMI on haemostasis: Implications for thrombosis in women's health. | Hunt BJ | β | 2017 | β |
| The Effect of Morbid Obesity on Subarachnoid Hemorrhage Prognosis in the United States. | Elliott RS et al. | β | 2017 | β |
| The Presence of Pretransplant Antiphospholipid Antibodies IgA Anti-Ξ²-2-Glycoprotein I as a Predictor of Graft Thrombosis After Renal Transplantation. | Morales JM et al. | β | 2017 | β |
| The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary SjΓΆgren Syndrome: A General Population-based Study. | AviΓ±a-Zubieta JA et al. | β | 2017 | β |
| The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis. | Marszalek J et al. | β | 2017 | β |
| Thrombin Generation in Patients With Suspected Venous Thromboembolism. | Wexels F et al. | β | 2017 | β |
| Transition and heavy metals compared to oxidative parameter balance in patients with deep vein thrombosis: A case-control study. | Ferrante M et al. | β | 2017 | β |
| Venous and Arterial Thrombosis: Is There a Link? | Prandoni P | β | 2017 | β |
| Venous thromboembolic events in critically ill traumatic brain injury patients. | Skrifvars MB et al. | β | 2017 | β |
| ABO Blood Group and Risk of Thromboembolic and Arterial Disease: A Study of 1.5 Million Blood Donors. | Vasan SK et al. | β | 2016 | β |
| Admission Glucose Level Predicts In-hospital Mortality in Patients with Acute Pulmonary Embolism Who Were Treated with Thrombolytic Therapy. | Bozbay M et al. | β | 2016 | β |
| Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis. | King DA et al. | β | 2016 | β |
| Association between migraine and risk of venous thromboembolism: A nationwide cohort study. | Peng KP et al. | β | 2016 | β |
| Association between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study. | Chiu CC et al. | β | 2016 | β |
| Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The TromsΓΈ Study. | SmΓ₯brekke B et al. | β | 2016 | β |
| Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis. | Bezinover D et al. | β | 2016 | β |
| Cancer, other comorbidity, and risk of venous thromboembolism after stroke: a population-based cohort study. | Corraini P et al. | β | 2016 | β |
| Can we prevent venous thrombosis with statins: an epidemiologic review into mechanism and clinical utility. | Lijfering WM et al. | β | 2016 | β |
| Case report: Limb-threatening femoral vein thrombosis in a healthy carpet fitter: Carpet fitter's thrombosis. | Rothnie A et al. | β | 2016 | β |
| Clinical Presentation, Management, and Outcomes of Deep Vein Thrombosis Based on Doppler Ultrasonography Examination. | Al-Thani H et al. | β | 2016 | β |
| Complement C3 and High Risk of Venous Thromboembolism: 80517 Individuals from the Copenhagen General Population Study. | NΓΈrgaard I et al. | β | 2016 | β |
| Coronary or thoracic artery calcium score in provoked and unprovoked pulmonary embolism: a case-control study. | van der Bijl N et al. | β | 2016 | β |
| C-reactive protein, obesity, and the risk of arterial and venous thrombosis. | Horvei LD et al. | β | 2016 | β |
| Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis. | Bell EJ et al. | β | 2016 | β |
| Does diabetes type increase the odds of venous thromboembolism following traumatic injury? | Leonard J et al. | β | 2016 | β |
| Effect of thromboprophylaxis with anticoagulant drugs on the incidence of arterial thrombotic events in medical inpatients: a systematic review. | Squizzato A et al. | β | 2016 | β |
| Elevated risk of venous thromboembolic events in patients with inflammatory myopathies. | Nowak M et al. | β | 2016 | β |
| Environmental and Genetic Risk Factors Associated with Venous Thromboembolism. | Crous-Bou M et al. | β | 2016 | β |
| Epidemiology of chronic thromboembolic pulmonary hypertension in Korea: results from the Korean registry. | Park SY et al. | β | 2016 | β |
| Epidemiology of venous thromboembolism in the Framingham Heart Study. | Puurunen MK et al. | β | 2016 | β |
| Fatal Pulmonary Thromboembolism in Patients with Diabetic Ketoacidosis: A Seven-Case Series and Review of the Literature. | Scordi-Bello I et al. | β | 2016 | β |
| Higher Levels of Serum Triglycerides were Associated with Postoperative Deep Vein Thrombosis After Total Hip Arthroplasty in Patients with Nontraumatic Osteonecrosis of the Femoral Head. | Xu Z et al. | β | 2016 | β |
| High prevalence of severe coronary artery disease in elderly patients with non-operable chronic thromboembolic pulmonary hypertension referred for balloon pulmonary angioplasty. | Roik M et al. | β | 2016 | β |
| How long should we fear? Long-term risk of venous thromboembolism in patients with traumatic brain injury. | Olufajo OA et al. | β | 2016 | β |
| Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer. | Zhang Y et al. | β | 2016 | β |
| Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol. | Arnold JD et al. | β | 2016 | β |
| Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies. | Gariani K et al. | β | 2016 | β |
| Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism. | Blann AD et al. | β | 2016 | β |
| Novel genetic predictors of venous thromboembolism risk in African Americans. | Hernandez W et al. | β | 2016 | β |
| Nutritional management of a patient with obesity and pulmonary embolism: a case report. | Fonte ML et al. | β | 2016 | β |
| Potential Risk Factors Associated With Vascular Diseases in Patients Receiving Treatment for Hypertension. | Kim H et al. | β | 2016 | β |
| Prevention of venous thromboembolism amongst patients in an acute tertiary referral teaching public hospital: a best practice implementation project. | Sykes PK et al. | β | 2016 | β |
| Progestin-only contraception and thromboembolism: A systematic review. | Tepper NK et al. | β | 2016 | β |
| Real-Time Label-Free Embolus Detection Using In Vivo Photoacoustic Flow Cytometry. | Juratli MA et al. | β | 2016 | β |
| Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis. | Fantony JJ et al. | β | 2016 | β |
| Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis. | Fantony JJ et al. | β | 2016 | β |
| Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients. | Yu I et al. | β | 2016 | β |
| Risk of Venous Thromboembolism in Patients with Large Hemispheric Infarction Undergoing Decompressive Hemicraniectomy. | Chalouhi N et al. | β | 2016 | β |
| Safety and Efficacy of High-Dose Unfractionated Heparin for Prevention of Venous Thromboembolism in Overweight and Obese Patients. | Joy M et al. | β | 2016 | β |
| Serum uric acid is associated with increased risk of idiopathic venous thromboembolism in high HDL-C population: A case-control study. | Yu M et al. | β | 2016 | β |
| Silent pulmonary thromboembolism in neurosurgery patients: Report of 2 cases and literature review. | Tian R et al. | β | 2016 | β |
| Statins and prevention of venous thromboembolism: Myth or reality? | Gaertner S et al. | β | 2016 | β |
| The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety. | Ihaddadene R et al. | β | 2016 | β |
| Thrombosis in the setting of obesity or inflammatory bowel disease. | Lentz SR | β | 2016 | β |
| Thrombosis in the setting of obesity or inflammatory bowel disease. | Lentz SR | β | 2016 | β |
| Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies. | Di Nisio M et al. | β | 2016 | β |
| Type 2 diabetes is associated with a higher incidence of hospitalization for pulmonary embolism in Spain: Analysis of hospital discharge data during 2004-2013. | de Miguel-DΓez J et al. | β | 2016 | β |
| Venous thromboembolism and risk of cancer in patients with diabetes mellitus. | Christensen DH et al. | β | 2016 | β |
| Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis. | Mi Y et al. | β | 2016 | β |
| American Heart Association's Life's Simple 7 and risk of venous thromboembolism: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. | Olson NC et al. | β | 2015 | β |
| Arterial cardiovascular events and mortality following venous thromboembolism. | Adelborg K et al. | β | 2015 | β |
| Association of body mass index and morbidity after abdominal, vaginal, and laparoscopic hysterectomy. | Shah DK et al. | β | 2015 | β |
| Can venous thromboembolism navigate the prevention of cardiovascular complications? | Shantsila A et al. | β | 2015 | β |
| Characteristics and Risk Factors of Cancer Associated Venous Thromboembolism. | Faiz AS et al. | β | 2015 | β |
| Coexistence of High Fibrinogen and Low High-density Lipoprotein Cholesterol Levels Predicts Recurrent Cerebral Venous Thrombosis. | Ma X et al. | β | 2015 | β |
| Complex kidneys for complex patients: the risk associated with transplantation of kidneys with multiple arteries into obese patients. | Nath J et al. | β | 2015 | β |
| Determinants of venous thromboembolism among hospitalizations of US adults: a multilevel analysis. | Tsai J et al. | β | 2015 | β |
| Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis. | Bai J et al. | β | 2015 | β |
| Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials. | Di Minno MN et al. | β | 2015 | β |
| Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation. | Riva N et al. | β | 2015 | β |
| Evaluating the cause of death in obese individuals: a ten-year medical autopsy study. | Saab J et al. | β | 2015 | β |
| Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. | Lim W et al. | β | 2015 | β |
| Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels. | Celik F et al. | β | 2015 | β |
| Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity. | Bouret S et al. | β | 2015 | β |
| Global hypercoagulability in patients with schizophrenia receiving long-term antipsychotic therapy. | Chow V et al. | β | 2015 | β |
| High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patients. | Samuel S et al. | β | 2015 | β |
| Is diabetes a hypercoagulable state? A critical appraisal. | Pomero F et al. | β | 2015 | β |
| Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study. | Klovaite J et al. | β | 2015 | β |
| Persistent global hypercoagulability in long-term survivors of acute pulmonary embolism. | Chow V et al. | β | 2015 | β |
| Re-evaluation of the anticoagulant properties of high-density lipoprotein-brief report. | Fernandez JA et al. | β | 2015 | β |
| Relationship Between Mean Platelet Volume and Pulmonary Embolism in Patients With Deep Vein Thrombosis. | Icli A et al. | β | 2015 | β |
| Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis. | Zhang J et al. | β | 2015 | β |
| Risk Factors of a Pulmonary Thromboembolism After Colorectal Surgery. | Kim J et al. | β | 2015 | β |
| The safety and efficacy of early-initiation exercise training after acute venous thromboembolism: a randomized clinical trial. | Lakoski SG et al. | β | 2015 | β |
| Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. | Jamal MH et al. | β | 2015 | β |
| Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab. | Al-Shamsi HO et al. | β | 2015 | β |
| Thyroid function, as assessed by TSH, and future risk of venous thromboembolism: the TromsΓΈ study. | Lerstad G et al. | β | 2015 | β |
| Trend and seasonality in hospitalizations for pulmonary embolism: a time-series analysis. | Guijarro R et al. | β | 2015 | β |
| Value of platelet indices in identifying complete resolution of thrombus in deep venous thrombosis patients. | Sevuk U et al. | β | 2015 | β |
| Venous thromboembolism and cardiovascular risk: results from the NAVIGATOR trial. | Katz M et al. | β | 2015 | β |
| Venous thromboembolism: An overview. | Bruni-Fitzgerald KR | β | 2015 | β |
| 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. | Konstantinides SV et al. | β | 2014 | β |
| A genomewide study of body mass index and its genetic correlation with thromboembolic risk. Results from the GAIT project. | Souto JC et al. | β | 2014 | β |
| Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. | Ishiguro C et al. | β | 2014 | β |
| Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. | Ageno W et al. | β | 2014 | β |
| [Association between venous thrombosis and dyslipidemia]. | GarcΓa Raso A et al. | β | 2014 | β |
| Case records of the Massachusetts General Hospital. Case 29-2014. A 60-year-old woman with syncope. | Kabrhel C et al. | β | 2014 | β |
| Concomitant deep venous thrombosis, femoral artery thrombosis, and pulmonary embolism after air travel. | Abunnaja S et al. | β | 2014 | β |
| D-dimer as a significant marker of deep vein thrombosis in patients with subclinical or overt Cushing's syndrome. | Fukuoka H et al. | β | 2014 | β |
| Difference in fibrinolytic capacity in young patients with venous thrombosis or ischaemic stroke. | Skov J et al. | β | 2014 | β |
| Different risk factor profiles between transient global amnesia and transient ischemic attack: a large case-control study. | Jang JW et al. | β | 2014 | β |
| Diverticular disease is associated with increased risk of subsequent arterial and venous thromboembolic events. | Strate LL et al. | β | 2014 | β |
| Effect of obesity on patients undergoing vaginal hysterectomy. | Muffly TM et al. | β | 2014 | β |
| Fish intake and venous thromboembolism: a Danish follow-up study. | Severinsen MT et al. | β | 2014 | β |
| Further evidence in support of the association between venous thrombosis and atherosclerosis: a case-control study. | Milan M et al. | β | 2014 | β |
| High-density lipoprotein as a modulator of platelet and coagulation responses. | van der Stoep M et al. | β | 2014 | β |
| High-throughput identification of off-targets for the mechanistic study of severe adverse drug reactions induced by analgesics. | Pan JB et al. | β | 2014 | β |
| Hyperglycemia, assessed according to HbA1c , and future risk of venous thromboembolism: the TromsΓΈ study. | Lerstad G et al. | β | 2014 | β |
| Immune function of peripheral T cells in patients with venous thromboembolism or coronary artery atherosclerosis. | Zhou L et al. | β | 2014 | β |
| Impact of obesity on mortality and complications in trauma patients. | Glance LG et al. | β | 2014 | β |
| Inflammatory plasma markers and risk for venous thromboembolism. | Sveinsdottir SV et al. | β | 2014 | β |
| Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism. | Bruzelius M et al. | β | 2014 | β |
| Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy. | Wells PS et al. | β | 2014 | β |
| Inhibition of renin angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic disease. | Chae YK et al. | β | 2014 | β |
| Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study. | Lu DY et al. | β | 2014 | β |
| Natural history of venous thromboembolism in patients from the Mediterranean region. A systematic review. | SΓ‘nchez MuΓ±oz-Torrero JF et al. | β | 2014 | β |
| Obesity measures and risk of venous thromboembolism and myocardial infarction. | Horvei LD et al. | β | 2014 | β |
| Ovarian vein thrombophlebitis related to large uterine myoma. | Haynes MC et al. | β | 2014 | β |
| Postpartum venous thromboembolism: incidence and risk factors. | Tepper NK et al. | β | 2014 | β |
| Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy. | Ferroni P et al. | β | 2014 | β |
| Prevalence of established risk factors for venous thromboembolism according to age. | Linnemann B et al. | β | 2014 | β |
| Prior myocardial infarction and presence of upper gastrointestinal conditions among patients with venous thromboembolism: prevalence, associated comorbidities and burden. | LaMori J et al. | β | 2014 | β |
| Proatherogenic oxidized low-density lipoprotein/Ξ²2-glycoprotein I complexes in arterial and venous disease. | Berger JS et al. | β | 2014 | β |
| Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism. | Wexels F et al. | β | 2014 | β |
| Quality improvement initiative to reduce deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. | Mermis JD et al. | β | 2014 | β |
| Race and venous thromboembolism: nature or nurture? | Goldhaber SZ | β | 2014 | β |
| Recurrent arterial and venous thromboemboli as initial presentation of acute promyelocytic leukemia. | Trottier-Tellier F et al. | β | 2014 | β |
| Relation between preclinical atherosclerosis and venous thromboembolism in patients with thrombophilias - longitudinal study. | AuzkΓ½ O et al. | β | 2014 | β |
| Risk assessment of deep-vein thrombosis after acute stroke: a prospective study using clinical factors. | Liu LP et al. | β | 2014 | β |
| Risk factors associated with myocardial infarction in venous thromboembolism patients. | LalibertΓ© F et al. | β | 2014 | β |
| Risk factors associated with the occurrence of silent pulmonary embolism in patients with deep venous thrombosis of the lower limb. | Li F et al. | β | 2014 | β |
| Sentinel lymph node biopsy versus axillary lymphadenectomy in patients treated with lumpectomy: an analysis of short-term outcomes. | Khavanin N et al. | β | 2014 | β |
| The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia. | Lekovic D et al. | β | 2014 | β |
| The relationship between vitamin D status and idiopathic lower-extremity deep vein thrombosis. | Khademvatani K et al. | β | 2014 | β |
| The survival detriment of venous thromboembolism with epithelial ovarian cancer. | Gunderson CC et al. | β | 2014 | β |
| Thrombotic risk factors in patients undergoing chemotherapy via peripherally inserted central catheter. | Shi Y et al. | β | 2014 | β |
| Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. | Ruggeri M et al. | β | 2014 | β |
| Trends, risk factors and mortality among women with venous thromboembolism during labour and delivery: a population-based study of 8 million births. | Abbasi N et al. | β | 2014 | β |
| Utility of noninvasive endothelial function test for prediction of deep vein thrombosis after total hip or knee arthroplasty. | Suzuki H et al. | β | 2014 | β |
| [Venous and arterial thrombosis: similarities and clinical implications]. | PΓ‘ramo FernΓ‘ndez JA | β | 2014 | β |
| Venous thromboembolism in patients with prior stroke. | Piazza G et al. | β | 2014 | β |
| 25-Hydroxyvitamin D concentrations and risk of venous thromboembolism in the general population with 18,791 participants. | BrΓΈndum-Jacobsen P et al. | β | 2013 | β |
| Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6. | Matos MF et al. | β | 2013 | β |
| Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. | Domecq JP et al. | β | 2013 | β |
| Alcohol intake and risk of venous thromboembolism. A Danish follow-up study. | Gaborit FS et al. | β | 2013 | β |
| Antithrombotic therapy in obesity. | Badimon L et al. | β | 2013 | β |
| Association between obstructive sleep apnea and pulmonary embolism. | Alonso-FernΓ‘ndez A et al. | β | 2013 | β |
| Body mass index, a major confounder to insulin resistance association with unprovoked venous thromboembolism. Results from the EDITH case-control study. | Delluc A et al. | β | 2013 | β |
| Clustering patterns of comorbidities associated with in-hospital death in hospitalizations of US adults with venous thromboembolism. | Tsai J et al. | β | 2013 | β |
| Cognitive test scores in young men and subsequent risk of type 2 diabetes, cardiovascular morbidity, and death. | Schmidt M et al. | β | 2013 | β |
| Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. | Cheng YJ et al. | β | 2013 | β |
| Current practices in preclinical drug development: gaps in hemostasis testing to assess risk of thromboembolic injury. | Schultze AE et al. | β | 2013 | β |
| Differential effects of nonselective versus selective Ξ²-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure. | de Peuter OR et al. | β | 2013 | β |
| Dyslipidemia is associated with tunneled-cuffed catheter-related central venous thrombosis in hemodialysis patients: a retrospective, multicenter study. | Cheng Y et al. | β | 2013 | β |
| Elevated serum amyloid A is associated with venous thromboembolism. | Deguchi H et al. | β | 2013 | β |
| Endometrial cancer: molecular and therapeutic aspects. | Tsikouras P et al. | β | 2013 | β |
| Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele. | Olivieri O et al. | β | 2013 | β |
| Factor Xa inhibitor attenuates leukocyte adhesion and thrombus formation in an experimental mouse model of the metabolic syndrome. | Iba T et al. | β | 2013 | β |
| Family history of myocardial infarction is a risk factor for venous thromboembolism among whites but not among blacks. | Mili FD et al. | β | 2013 | β |
| Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study. | Bell EJ et al. | β | 2013 | β |
| High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals. | ZΔ bczyk M et al. | β | 2013 | β |
| Long-term clinical course of acute pulmonary embolism. | den Exter PL et al. | β | 2013 | β |
| Low CD34(+) cells, high neutrophils and the metabolic syndrome are associated with an increased risk of venous thromboembolism. | Rattazzi M et al. | β | 2013 | β |
| Obesity and the microvasculature: a systematic review and meta-analysis. | Boillot A et al. | β | 2013 | β |
| Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study. | Schmidt M et al. | β | 2013 | β |
| Optimal treatment duration of venous thrombosis. | Ageno W et al. | β | 2013 | β |
| Overview and assessment of risk factors for pulmonary embolism. | Soo Hoo GW | β | 2013 | β |
| Overweight and obese middle-aged women have increased risk of venous thromboembolism, particularly following surgery. | McRae S | β | 2013 | β |
| Proteomic analysis of venous thromboembolism: an update. | Liumbruno GM et al. | β | 2013 | β |
| Risk factors for venous thromboembolism during pregnancy. | Jensen TB et al. | β | 2013 | β |
| Should alcohol be considered a minor protective factor for unprovoked venous thromboembolism? | Donadini MP et al. | β | 2013 | β |
| Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study. | Sweetland S et al. | β | 2013 | β |
| Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis. | Adams NB et al. | β | 2013 | β |
| Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study. | Nguyen CD et al. | β | 2013 | β |
| Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. | Zuily S et al. | β | 2013 | β |
| The association of smoking with venous thrombosis in women. A population-based, case-control study. | Blondon M et al. | β | 2013 | β |
| The influence of BMI on perioperative morbidity following abdominal hysterectomy. | Khavanin N et al. | β | 2013 | β |
| Thrombosis following acute cytomegalovirus infection: a community prospective study. | Paran Y et al. | β | 2013 | β |
| Thrombosis in central obesity and metabolic syndrome: mechanisms and epidemiology. | Morange PE et al. | β | 2013 | β |
| Venous thromboembolic events in germ cell cancer patients undergoing platinum-based chemotherapy. | Honecker F et al. | β | 2013 | β |
| Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. | Koutroumpi S et al. | β | 2013 | β |
| Venous thromboembolism in subarachnoid hemorrhage. | Serrone JC et al. | β | 2013 | β |
| Venous thromboembolism in women: a specific reproductive health risk. | ESHRE Capri Workshop Group | β | 2013 | β |
| Adherence to statins is associated with reduced incidence of idiopathic venous thromboembolism: real-life data from a large healthcare maintenance organisation. | Rabinowich L et al. | β | 2012 | β |
| Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. | Wattanakit K et al. | β | 2012 | β |
| Association between venous and arterial thrombosis: clinical implications. | Franchini M et al. | β | 2012 | β |
| Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts. | Mahmoodi BK et al. | β | 2012 | β |
| A unique presentation of four thrombotic events at a time. | Rajani AR et al. | β | 2012 | β |
| Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. | Parkin L et al. | β | 2012 | β |
| Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. | van Langevelde K et al. | β | 2012 | β |
| Comparative study on the effectiveness of myofascial release manual therapy and physical therapy for venous insufficiency in postmenopausal women. | Ramos-GonzΓ‘lez E et al. | β | 2012 | β |
| Comparison of clinical and imaging characteristics and outcomes between provoked and unprovoked acute pulmonary embolism in Koreans. | Uhm JS et al. | β | 2012 | β |
| Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study. | BrΓ¦kkan SK et al. | β | 2012 | β |
| Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. | Rahimi K et al. | β | 2012 | β |
| Elevated admission glucose and mortality in patients with acute pulmonary embolism. | Scherz N et al. | β | 2012 | β |
| Epicardial adipose tissue and idiopathic deep venous thrombosis: an association study. | Mazzoccoli G et al. | β | 2012 | β |
| [Epidemiology and risk factors of venous thromboembolism]. | Delluc A et al. | β | 2012 | β |
| Epidemiology of venous thromboembolism: the need for large (including prospective) studies and meta-analyses. | Lowe GD | β | 2012 | β |
| Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice. | Brill A et al. | β | 2012 | β |
| Formation of the venous thrombus after venous occlusion in the experimental mouse model of metabolic syndrome. | Iba T et al. | β | 2012 | β |
| Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. | Di Minno MN et al. | β | 2012 | β |
| Idiopathic deep venous thrombosis and arterial endothelial dysfunction in the elderly. | Mazzoccoli G et al. | β | 2012 | β |
| Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. | Van Schouwenburg IM et al. | β | 2012 | β |
| Invited commentary: Diet and risk of venous thromboembolism--a hard nut to crack. | Lutsey PL | β | 2012 | β |
| Lipid lowering drugs and the risk of recurrent venous thromboembolism. | Delluc A et al. | β | 2012 | β |
| Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism. | Delluc A et al. | β | 2012 | β |
| Maternal obesity and venous thromboembolism. | Morgan ES et al. | β | 2012 | β |
| Mean platelet volume is increased in patients with deep vein thrombosis. | Gulcan M et al. | β | 2012 | β |
| Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients. | Ayala R et al. | β | 2012 | β |
| Perioperative optimization of patients undergoing bariatric surgery. | Owers CE et al. | β | 2012 | β |
| Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. | Wolberg AS et al. | β | 2012 | β |
| Should the commonly accepted definition of "unprovoked venous thrombembolism" be revisited? | Ageno W et al. | β | 2012 | β |
| Simultaneous MR arteriography and venography with blood pool contrast agent detects deep venous thrombosis in suspected arterial disease. | Hadizadeh DR et al. | β | 2012 | β |
| Sleep apnea and risk of deep vein thrombosis: a non-randomized, pair-matched cohort study. | Chou KT et al. | β | 2012 | β |
| Stroke and renal dysfunction: are we always conscious of this relationship? | Fabbian F et al. | β | 2012 | β |
| Systematic reviews synthesized evidence without consistent quality assessment of primary studies examining epidemiology of chronic diseases. | Shamliyan T et al. | β | 2012 | β |
| The association between body mass index and pulmonary thromboembolism in an autopsy population. | Rosenfeld HE et al. | β | 2012 | β |
| The effects of obesity on venous thromboembolism: A review. | Yang G et al. | β | 2012 | β |
| The effects of weight loss due to gastric banding and lifestyle modification on red blood cell aggregation and deformability in severe obese subjects. | Capuano P et al. | β | 2012 | β |
| The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies. | Dennis J et al. | β | 2012 | β |
| Venous thromboembolism: epidemiology and magnitude of the problem. | Goldhaber SZ | β | 2012 | β |
| Venous thromboembolism in patients with diabetes mellitus. | Piazza G et al. | β | 2012 | β |
| Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism. | Di Minno MN et al. | β | 2011 | β |
| Adipokines and thrombosis. | SchΓ€fer K et al. | β | 2011 | β |
| Dose-related effect of statins in venous thrombosis risk reduction. | Khemasuwan D et al. | β | 2011 | β |
| Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women. | Bouligand J et al. | β | 2011 | β |
| Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. | Di Minno MN et al. | β | 2011 | β |
| HDL scavenger receptor class B type I and platelet function. | Nofer JR et al. | β | 2011 | β |
| High levels of glucose at time of diagnosing venous thrombosis: a case-control study. | Tichelaar YI et al. | β | 2011 | β |
| High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study. | Hald EM et al. | β | 2011 | β |
| Homocysteine and serum-lipid levels in pulmonary embolism. | Karalezli A et al. | β | 2011 | β |
| Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences. | Smalberg JH et al. | β | 2011 | β |
| Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. | Tripodi A et al. | β | 2011 | β |
| Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapy. | Tselepis AD et al. | β | 2011 | β |
| Involvement of microparticles in diabetic vascular complications. | Tsimerman G et al. | β | 2011 | β |
| Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids. | Brodde MF et al. | β | 2011 | β |
| Obesity, poor muscle strength, and venous thromboembolism in older persons: the InCHIANTI study. | Di Nisio M et al. | β | 2011 | β |
| Platelet indices in patients with acute pulmonary embolism. | Varol E et al. | β | 2011 | β |
| Pregnancy-induced hypertension, but not gestational diabetes mellitus, is a risk factor for venous thromboembolism in pregnancy. | Won HS et al. | β | 2011 | β |
| Prevalence of arterial and venous thromboembolic events in diabetic patients with and without the metabolic syndrome: a cross sectional study. | Dentali F et al. | β | 2011 | β |
| Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome. | Talens S et al. | β | 2011 | β |
| Racial differences in venous thromboembolism. | Zakai NA et al. | β | 2011 | β |
| Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database. | Clayton TC et al. | β | 2011 | β |
| Review for hospitalists: acute pulmonary embolism. | Adams AG et al. | β | 2011 | β |
| Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers. | Dolic K et al. | β | 2011 | β |
| Risk factors for venous and arterial thrombosis. | Previtali E et al. | β | 2011 | β |
| Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. | Douketis J et al. | β | 2011 | β |
| Seasonal and monthly variability in the incidence of venous thromboembolism. A systematic review and a meta-analysis of the literature. | Dentali F et al. | β | 2011 | β |
| Tailoring combination oral contraceptives to the individual woman. | Archer DF et al. | β | 2011 | β |
| The impact of co-morbid conditions on family history of venous thromboembolism in Whites and Blacks. | Mili FD et al. | β | 2011 | β |
| The metabolic syndrome in critically ill patients. | Robinson K et al. | β | 2011 | β |
| Traffic exposure and incident venous thromboembolism in the Atherosclerosis Risk in Communities (ARIC) Study. | Kan H et al. | β | 2011 | β |
| Venous and arterial thrombosis in dialysis patients. | Ocak G et al. | β | 2011 | β |
| Venous thromboembolism in patients with symptomatic atherosclerosis. | Piazza G et al. | β | 2011 | β |
| Which patients with unprovoked VTE should receive extended anticoagulation? the minority. | Donadini MP et al. | β | 2011 | β |
| Winter and venous thromboembolism: a dangerous liaison? | Manfredini R et al. | β | 2011 | β |
| Acquired thrombotic risk factors in the critical care setting. | Ortel TL | β | 2010 | β |
| Acute pulmonary embolism. Part 1: epidemiology and diagnosis. | Douma RA et al. | β | 2010 | β |
| Advantages and challenges of oestrogen-free hormonal contraception. | Ahrendt HJ et al. | β | 2010 | β |
| Ambulatory surgery: how much testing do we need? | Richman DC | β | 2010 | β |
| Antihypertensive drugs and risk of venous thromboembolism: results from the EDITH case-control study. | Belattar FZ et al. | β | 2010 | β |
| Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). | Quist-Paulsen P et al. | β | 2010 | β |
| Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients. | Cheung MC et al. | β | 2010 | β |
| Circulating procoagulant microparticles in acute pulmonary embolism: a case-control study. | Bal L et al. | β | 2010 | β |
| Correlation study of pulmonary embolism and high-density lipoprotein cholesterol. | Wang Y et al. | β | 2010 | β |
| Diet as prophylaxis and treatment for venous thromboembolism? | Cundiff DK et al. | β | 2010 | β |
| Endothelial progenitor cells as a new cardiovascular risk factor in Klinefelter's syndrome. | Di Mambro A et al. | β | 2010 | β |
| Estrogen-free oral hormonal contraception: benefits of the progestin-only pill. | de Melo NR | β | 2010 | β |
| Expanding the clinical spectrum of OSA--an association with pulmonary embolism? | Cistulli PA et al. | β | 2010 | β |
| Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. | Bal L et al. | β | 2010 | β |
| Frequency of prothrombotic risk factors in patients with deep venous thrombosis and controls: their implications for thrombophilia screening in Chilean subjects. | GuzmΓ‘n N et al. | β | 2010 | β |
| Hematocrit and risk of venous thromboembolism in a general population. The Tromso study. | Braekkan SK et al. | β | 2010 | β |
| High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. | Nofer JR et al. | β | 2010 | β |
| HIV is associated with thrombophilia and high D-dimer in children and adolescents. | Pontrelli G et al. | β | 2010 | β |
| Hypercoagulable state, pathophysiology, classification and epidemiology. | AlfireviΔ Z et al. | β | 2010 | β |
| Hyperglycemia: a prothrombotic factor? | Lemkes BA et al. | β | 2010 | β |
| Idiopathic venous thrombosis is associated with preclinical atherosclerosis. | Jezovnik MK et al. | β | 2010 | β |
| Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. | Becattini C et al. | β | 2010 | β |
| Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT. | Vergeer M et al. | β | 2010 | β |
| Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. | Nelson SM et al. | β | 2010 | β |
| Mean platelet volume is a risk factor for venous thromboembolism: the TromsΓΈ Study, TromsΓΈ, Norway. | Braekkan SK et al. | β | 2010 | β |
| Mean platelet volume predicts early death in acute pulmonary embolism. | Kostrubiec M et al. | β | 2010 | β |
| Obesity, smoking, and frontal brain dysfunction. | Bauer L et al. | β | 2010 | β |
| Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options. | RachoΕ D et al. | β | 2010 | β |
| Predictors of chronic disease at midlife and beyond--the health risks of obesity. | Nejat EJ et al. | β | 2010 | β |
| Prevention of thrombosis after microvascular tissue transfer in the head and neck. A review of the literature and the state of affairs in Dutch Head and Neck Cancer Centers. | Brands MT et al. | β | 2010 | β |
| Prevention of venous thromboembolism in obesity. | Freeman AL et al. | β | 2010 | β |
| Pulmonary embolism in Black Americans. | Goldhaber SZ | β | 2010 | β |
| Pulmonary thromboembolic disease. Clinical management of acute and chronic disease. | Torbicki A | β | 2010 | β |
| Quality of systematic reviews of observational nontherapeutic studies. | Shamliyan T et al. | β | 2010 | β |
| Risk factors for venous thromboembolism. | Goldhaber SZ | β | 2010 | β |
| Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. | Holst AG et al. | β | 2010 | β |
| Risk factors for venous thrombosis - current understanding from an epidemiological point of view. | Lijfering WM et al. | β | 2010 | β |
| Statins and prophylaxis of venous thrombosis - a further link between arterial and venous thrombosis. | Shantsila A et al. | β | 2010 | β |
| Statins, fibrates, and venous thromboembolism: a meta-analysis. | Squizzato A et al. | β | 2010 | β |
| Temporal patterns of hospital admissions for transient ischemic attack: a retrospective population-based study in the Emilia-Romagna region of Italy. | Manfredini R et al. | β | 2010 | β |
| The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. | Sandhu R et al. | β | 2010 | β |
| Venous thromboembolism and atherothrombosis: an integrated approach. | Piazza G et al. | β | 2010 | β |
| Venous thromboembolism and subsequent diagnosis of subarachnoid hemorrhage: a 20-year cohort study. | SΓΈrensen HT et al. | β | 2010 | β |
| Venous thromboembolism in hospitalized patients with heart failure: incidence, prognosis, and prevention. | Ng TM et al. | β | 2010 | β |
| Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing. | Mahan CE et al. | β | 2010 | β |
| Venous thrombosis in the elderly: incidence, risk factors and risk groups. | Engbers MJ et al. | β | 2010 | β |
| Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the TromsΓΈ study. | Borch KH et al. | β | 2009 | β |
| A new indication for statins to prevent venous thromboembolism? Not yet. | Cushman M | β | 2009 | β |
| Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. | Severinsen MT et al. | β | 2009 | β |
| Antipsychotics and risk of venous thromboembolism: A population-based case-control study. | JΓΆnsson AK et al. | β | 2009 | β |
| [Antithrombotic prophylaxis after THA and TKA: the surgeon's point of view]. | Vielpeau C et al. | β | 2009 | β |
| A randomized trial of rosuvastatin in the prevention of venous thromboembolism. | Glynn RJ et al. | β | 2009 | β |
| Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. | SΓΈrensen HT et al. | β | 2009 | β |
| Assessing the risk of venous thromboembolism and identifying barriers to thromboprophylaxis in the hospitalized patient. | McKean SC et al. | β | 2009 | β |
| C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort. | Folsom AR et al. | β | 2009 | β |
| Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study. | Svartberg J et al. | β | 2009 | β |
| HDL-cholesterol and future risk of venous thromboembolism: the TromsΓΈ Study. | Braekkan SK et al. | β | 2009 | β |
| Hormonal contraceptive regimens in the perimenopause. | Hardman SM et al. | β | 2009 | β |
| Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. | Heit JA et al. | β | 2009 | β |
| Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women. | Everett BM et al. | β | 2009 | β |
| Living near major traffic roads and risk of deep vein thrombosis. | Baccarelli A et al. | β | 2009 | β |
| Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology. | Steffen LM et al. | β | 2009 | β |
| Metabolic syndrome is associated with venous thromboembolism in the Korean population. | Jang MJ et al. | β | 2009 | β |
| Obesity, metabolic syndrome, and the surgical patient. | Levin PD et al. | β | 2009 | β |
| Obesity, metabolic syndrome, and the surgical patient. | Levin PD et al. | β | 2009 | β |
| Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross-sectional survey. | Prandoni P et al. | β | 2009 | β |
| Serious venous thromboembolism, heterozygous factor V Leiden and prothrombin G20210A mutations in a patient with Klinefelter syndrome and type 2 diabetes. | Ayli M et al. | β | 2009 | β |
| Smoking and venous thromboembolism: a Danish follow-up study. | Severinsen MT et al. | β | 2009 | β |
| Venous and arterial thrombosis: two aspects of the same disease? | Prandoni P | β | 2009 | β |
| Venous and arterial thrombosis: Two aspects of the same disease? | Prandoni P | β | 2009 | β |
| Venous thrombo-embolism and aortic calcifications; more evidence on the link between venous and arterial thrombosis. | Rafi S et al. | β | 2009 | β |
| Venous thromboembolism: risk factors for recurrence. | Zhu T et al. | β | 2009 | β |
| Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study. | Hermanides J et al. | β | 2009 | β |
| Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the TromsΓΈ study. | Braekkan SK et al. | β | 2008 | β |
| First episode and recurrent venous thromboembolism: who is identifiably at risk? | Liem TK et al. | β | 2008 | β |
| Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. | Mahmoodi BK et al. | β | 2008 | β |
| High-density lipoprotein cholesterol and venous thromboembolism in the Longitudinal Investigation of Thromboembolism Etiology (LITE). | Chamberlain AM et al. | β | 2008 | β |
| Silent venous thromboembolism before treatment in endometrial cancer and the risk factors. | Satoh T et al. | β | 2008 | β |
| [What's new in internal medicine?]. | FrancΓ¨s C | β | 2008 | β |